about
Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic reviewFollow-up of patients with multidrug resistant tuberculosis four years after standardized first-line drug treatmentThe effect of tuberculosis on mortality in HIV positive people: a meta-analysis.The incremental cost-effectiveness of engaging private practitioners to refer tuberculosis suspects to DOTS services in Jogjakarta, Indonesia.Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic reviewAssessing tuberculosis case fatality ratio: a meta-analysis.Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.Towards tuberculosis elimination: an action framework for low-incidence countriesManagement of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries.Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysisProtecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones.HIV and Schistosoma haematobium prevalences correlate in sub-Saharan Africa.Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains.Is tuberculosis crossing borders at the Eastern boundary of the European Union?Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement.Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014.Closing the gap in surveillance of tuberculosis and HIV co-infection: a European perspective on the need for clinician-public health alliances.ERS/ECDC Statement: European Union Standards for Tuberculosis Care - 2017 update.Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysisFactors associated with non-adherence during tuberculosis treatment among patients treated with DOTS strategy in Jayapura, Papua Province, IndonesiaEuropean Union standard for tuberculosis care on treatment of multidrug-resistant tuberculosis following new World Health Organization recommendationsGuidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area
P50
Q26864753-8F1EF29B-6AF2-428A-8597-77B64C9EECE1Q28474035-76143E91-BD91-4B23-94ED-0034B1A5BC3AQ30994512-D429D6F4-5C42-4032-B24F-9E3239405CAEQ33592697-6C836248-EE5C-47FE-B2DD-A1FC9267F9D8Q33869390-BC14FAAF-B27B-4B03-BD5D-6E7120A0BE6FQ33954598-92078717-058A-4F9C-992F-05E5AB2A8E6DQ34551560-2393F76A-6BBC-4281-8D74-27C08E5AC542Q35344151-49174515-A60C-435C-9F20-FC8466045E36Q35787450-80D07977-75F2-458C-A059-BC654D5935AAQ36001543-BBA3ABDA-B3B4-4BCE-B48C-46A7BDAA2773Q36288667-996B600B-DF5B-4387-9871-77BA7F8B2B31Q36701899-143AEAA7-1079-4BC2-AB4E-04CD9C107B4AQ37133287-42E6239F-F92D-49C5-90A9-7B65F3D93C2AQ37343572-81E7EDF5-27FB-44B5-9611-6E5B5E3764B0Q42715629-240FBC7A-D7B5-4CD2-9351-746E6F2189C2Q45716617-AF237BA6-B170-408E-AAED-822CAF1290B0Q48288953-E1078720-D71E-44D7-88A2-C149FD1CEB03Q52573425-135DEE6F-16A8-4FA7-AAD3-0634CAEAAFB8Q56889741-3E5569DA-3DD7-44A3-A1D9-59B011549CA1Q58579980-9B78FE4D-427A-41A4-9040-9DACDC9479AAQ59240845-970A9A35-1CD7-41B8-B2C0-09BA695293EBQ91099227-7450B44C-6238-4F94-B7A9-135A96AF244B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marieke J. Van Der Werf
@ast
Marieke J. Van Der Werf
@en
Marieke J. Van Der Werf
@es
Marieke J. Van Der Werf
@fr
Marieke J. Van Der Werf
@nl
Marieke J. Van Der Werf
@sl
type
label
Marieke J. Van Der Werf
@ast
Marieke J. Van Der Werf
@en
Marieke J. Van Der Werf
@es
Marieke J. Van Der Werf
@fr
Marieke J. Van Der Werf
@nl
Marieke J. Van Der Werf
@sl
prefLabel
Marieke J. Van Der Werf
@ast
Marieke J. Van Der Werf
@en
Marieke J. Van Der Werf
@es
Marieke J. Van Der Werf
@fr
Marieke J. Van Der Werf
@nl
Marieke J. Van Der Werf
@sl
P106
P21
P31
P496
0000-0001-8021-1358